/

Ovid Therapeutics

Develops small molecule medicines for rare neurological brain disorders

BiotechnologyPharmaceuticals ovidrx.com ↗

Company facts

Founded: 2014
Employees: 23
Headquarters: United States
Type: Public
Listed: NASDAQ: OVID